Altre lingue Kwality Pharmaceuticals Limited

Azioni

KPL6

INE552U01010

Mercato chiuso - Bombay S.E. Altri mercati azionari 12:19:01 26/04/2024			Variaz. 5gg	Var. 1 gen.
507 ^INR	+1,36%		+13,03%	+26,81%

06/02	Kwality Pharmaceuticals Limited riporta i risultati degli utili per i nove mesi conclusi il 31 dicembre 2023	CI
2023	Kwality Pharmaceuticals Limited riporta i risultati degli utili per il secondo trimestre e i sei mesi conclusi il 30 settembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Kwality Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	06/02
Kwality Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	04/11
Kwality Pharmaceuticals Limited Provides Update on Resumption of Operations At Amritsar	07/10/23
Kwality Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	10/08/23
Kwality Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	27/05/23
Kwality Pharmaceuticals Discloses Completion of EU GMP Inspection at Himachal Pradesh, India Unit	25/04/23
Kwality Pharmaceuticals Limited Receives ANVISA Approval for Cephalosporin Plant (Unit -II)	30/03/23
Kwality Pharmaceuticals Limited Announces Change in Directorate	18/03/23
Kwality Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	14/02/23
Bulgarian Drug Agency to Conduct Audit on Kwality Pharmaceuticals' Plant in Himachal Pradesh, India	28/12/22
Kwality Pharmaceuticals to Bring Oncology Injection in Brazil	21/12/22
Kwality Pharmaceuticals to Market Oncology Injection in Brazil	15/12/22
Kwality Pharmaceuticals Received ANVISA Approval For Oncology Injection	15/12/22
Kwality Pharmaceuticals Receives ANVISA Approval For Oncology Injection	15/12/22
Kwality Pharmaceuticals Limited Announces the Resignation of Sachin Seth as Non- Executive and Non Independent Director	19/11/22
Kwality Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	14/11/22
ICRA Assigns BBB Rating on Kwality Pharmaceuticals' Bank Loans; Outlook Stable	21/09/22
Kwality Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	13/08/22
Kwality Pharmaceuticals Gets In-Principle Approval to Migrate to BSE Main Board	03/06/22
Kwality Pharmaceuticals Limited Provides Earnings Guidance for the Fiscal Year 2023	28/05/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Kwality Pharmaceuticals Limited

Azioni

KPL6

INE552U01010

Altre lingue

Filtri